Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group

PURPOSE: To investigate whether event-free survival (EFS) can be maintained among children and adolescents with intermediate-risk (IR) malignant germ cell tumors (MGCT) if the administration of cisplatin, etoposide, and bleomycin (PEb) is reduced from four to three cycles and compressed from 5 to 3...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Shaikh, Furqan, Cullen, John W., Olson, Thomas A., Pashankar, Farzana, Malogolowkin, Marcio H., Amatruda, James F., Villaluna, Doojduen, Krailo, Mark, Billmire, Deborah F., Rescorla, Frederick J., Egler, Rachel A., Dicken, Bryan J., Ross, Jonathan H., Schlatter, Marc, Rodriguez-Galindo, Carlos, Frazier, A. Lindsay
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2017
Aiheet:
ORIGINAL REPORTS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455599/
https://ncbi.nlm.nih.gov/pubmed/28240974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.6544
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia